Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 4;18(1):67.
doi: 10.1186/s13223-022-00711-0.

The effect of intra-nasal tetra sodium pyrophosphate on decreasing elevated nasal calcium and improving olfactory function post COVID-19: a randomized controlled trial

Affiliations

The effect of intra-nasal tetra sodium pyrophosphate on decreasing elevated nasal calcium and improving olfactory function post COVID-19: a randomized controlled trial

Mohamed H Abdelazim et al. Allergy Asthma Clin Immunol. .

Abstract

Background: Olfactory dysfunction is recognized as a symptom of COVID-19. Reports revealed the nasal calcium increase has adverse effects on olfactory function. Tetra sodium pyrophosphate, a chelating agent, can bind calcium and help improve olfaction.

Methods: Sixty-four patients with olfactory dysfunction persisting for more than 90 days after COVID-19 were recruited. Participants were divided into 2 groups that received either 0.9% sodium chloride or 1% tetra sodium pyrophosphate for topical application. Olfactory function was tested with the Sniffin' Sticks test before treatment and 1 month later. In addition, nasal calcium was determined with an ion-selective electrode.

Results: After topical application of tetra sodium pyrophosphate compared to sodium chloride, improvement from anosmia to hyposmia with decrease in calcium level was demonstrated. As for the results of tetra-sodium pyrophosphate, 81% showed improved olfactory function and 19% did not exhibit olfaction improvement.

Conclusions: Intranasal application of tetra sodium pyrophosphate may be associated with improvement in olfactory function after COVID -19 infection. Trial registration Ethical Committee of Damietta Faculty of Medicine approved this study on January 2021 (approval number, IRB 00012367-21-03-010).

Keywords: COVID-19; Calcium; Chelating agent; Olfactory disorder; Tetra sodium pyrophosphate.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The flow chart of the described study
Fig. 2
Fig. 2
The chemical reaction pathway of TSPP and calcium

Similar articles

Cited by

References

    1. Sharma A, Kumar R, Aier I, Semwal R, Tyagi P, Varadwaj P. Sense of smell: structural, functional, mechanistic advancements and challenges in human olfactory research. Curr Neuropharmacol. 2019;17(9):891–911. doi: 10.2174/1570159X17666181206095626. - DOI - PMC - PubMed
    1. Su C-Y, Menuz K, Carlson JR. Olfactory perception: receptors, cells, and circuits. Cell. 2009;139(1):45–59. doi: 10.1016/j.cell.2009.09.015. - DOI - PMC - PubMed
    1. Sell CS. Chemistry and the Sense of Smell. Hoboken: Wiley; 2014.
    1. González LM, Graham RK, Frigon A, Cohen A. Abnormalities in the olfactory system and its modulation as a therapeutic approach in mild cognitive impairment. 2021.
    1. Menini A. Calcium signalling and regulation in olfactory neurons. Curr Opin Neurobiol. 1999;9(4):419–426. doi: 10.1016/S0959-4388(99)80063-4. - DOI - PubMed